Artelo Biosciences, Inc. has announced a successful underwritten offering, resulting in the issuance of 640,924 shares of common stock at a price of $4.40 per share, alongside pre-funded warrants for an additional 40,894 shares at an exercise price of $0.001 per share. This offering has generated approximately $3 million in gross proceeds, prior to the deduction of underwriting discounts, commissions, and other expenses. The sole book-running manager for this transaction was R. F. Lafferty & Co., Inc. Additionally, the underwriter's 45-day over-allotment option was partially exercised, leading to the purchase of an additional 57,914 shares, contributing approximately $0.25 million in gross proceeds.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artelo Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001640334-25-001680), on September 15, 2025, and is solely responsible for the information contained therein.